Recent Progress in the Development of TSPO PET Ligands for Neuroinflammation Imaging in Neurological Diseases

Neuroinflammation is heavily associated with various neurological diseases including Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, and stroke. It is strongly characterized by the activation of microglia which can be visualized using position emission tomography (PET). Traditionally, translocator protein 18 kDa (TSPO) has been the preferred target for imaging the inflammatory progression of the microglial component. TSPO is expressed in the outer mitochondrial membrane and present in very low concentrations in the healthy human brain, but is markedly upregulated in response to brain injury and inflammation. Due to its value as a marker of microglial activation and subsequent utility for evaluating neuroinflammation in CNS disorders, several classes of TSPO radioligands have been developed and evaluated. However, the application of these second-generation TSPO radiotracers has been subject to several limiting factors, including a polymorphism that affects TSPO binding. This review focuses on recent developments in TSPO imaging, as well as current limitations and suggestions for future directions from a medical imaging perspective.

[1]  Christer Halldin,et al.  Age and disease related changes in the translocator protein (TSPO) system in the human brain: Positron emission tomography measurements with [11C]vinpocetine , 2011, NeuroImage.

[2]  R. Maroy,et al.  18F-GE-180: a novel TSPO radiotracer compared to 11C-R-PK11195 in a preclinical model of stroke , 2015, European Journal of Nuclear Medicine and Molecular Imaging.

[3]  R. Boisgard,et al.  Radiosynthesis of 7-chloro-N,N-dimethyl-5-[11C]methyl-4-oxo-3- phenyl-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide, [11C] SSR180575, a novel radioligand for imaging the TSPO (peripheral benzodiazepine receptor) with PET , 2010 .

[4]  Roger N Gunn,et al.  Quantification of the Specific Translocator Protein Signal of 18F-PBR111 in Healthy Humans: A Genetic Polymorphism Effect on In Vivo Binding , 2013, The Journal of Nuclear Medicine.

[5]  S. Meikle,et al.  Synthesis and in vivo evaluation of a novel peripheral benzodiazepine receptor PET radioligand. , 2005, Bioorganic & medicinal chemistry.

[6]  Philippe Hantraye,et al.  11C-DPA-713: A Novel Peripheral Benzodiazepine Receptor PET Ligand for In Vivo Imaging of Neuroinflammation , 2007, Journal of Nuclear Medicine.

[7]  R. Boellaard,et al.  Quantification of [18F]DPA-714 binding in the human brain: initial studies in healthy controls and Alzheimer's disease patients , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[8]  Caroline Prunier,et al.  Molecular Imaging of Microglial Activation in Amyotrophic Lateral Sclerosis , 2012, PloS one.

[9]  P. Jones,et al.  Exploration of the impact of stereochemistry on the identification of the novel translocator protein PET imaging agent [(18)F]GE-180. , 2015, Nuclear medicine and biology.

[10]  Alan A. Wilson,et al.  Neuroinflammation in healthy aging: A PET study using a novel Translocator Protein 18kDa (TSPO) radioligand, [18F]-FEPPA , 2014, NeuroImage.

[11]  M. Thaning,et al.  [¹⁸F]GE-180: a novel fluorine-18 labelled PET tracer for imaging Translocator protein 18 kDa (TSPO). , 2012, Bioorganic & medicinal chemistry letters.

[12]  R. Butterworth,et al.  Characterization of binding sites for the omega3 receptor ligands [3H]PK11195 and [3H]RO5-4864 in human brain. , 1997, European journal of pharmacology.

[13]  Yamei Tang,et al.  Phagocytosis of Microglia in the Central Nervous System Diseases , 2014, Molecular Neurobiology.

[14]  Ho-Yyoung Lee,et al.  [(18)F]Fluoromethyl-PBR28 as a potential radiotracer for TSPO: preclinical comparison with [(11)C]PBR28 in a rat model of neuroinflammation. , 2014, Bioconjugate chemistry.

[15]  Giuseppe Trapani,et al.  Targeting of the translocator protein 18 kDa (TSPO): a valuable approach for nuclear and optical imaging of activated microglia. , 2013, Bioconjugate chemistry.

[16]  D. Nutt,et al.  Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. , 2006, Trends in pharmacological sciences.

[17]  Ming-Rong Zhang,et al.  [2-11C]isopropyl-, [1-11C]ethyl-, and [11C]methyl-labeled phenoxyphenyl acetamide derivatives as positron emission tomography ligands for the peripheral benzodiazepine receptor: radiosynthesis, uptake, and in vivo binding in brain. , 2006, Journal of medicinal chemistry.

[18]  Leah P. Dickstein,et al.  Comparison of 18F- and 11C-labeled aryloxyanilide analogs to measure translocator protein in human brain using positron emission tomography , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[19]  Tetsuya Suhara,et al.  11C-AC-5216: A Novel PET Ligand for Peripheral Benzodiazepine Receptors in the Primate Brain , 2007, Journal of Nuclear Medicine.

[20]  Philippe Hantraye,et al.  Reactive Astrocytes Overexpress TSPO and Are Detected by TSPO Positron Emission Tomography Imaging , 2012, The Journal of Neuroscience.

[21]  M. Kassiou,et al.  Could 18 F-DPA-714 PET imaging be interesting to use in the early post-stroke period? , 2014, EJNMMI Research.

[22]  Jeih-San Liow,et al.  Radiation Dosimetry and Biodistribution in Monkey and Man of 11C-PBR28: A PET Radioligand to Image Inflammation , 2007, Journal of Nuclear Medicine.

[23]  Pavan Reddy,et al.  Recent Advances and Future Directions , 2004 .

[24]  Abraham Weizman,et al.  Enigma of the peripheral benzodiazepine receptor. , 1999, Pharmacological reviews.

[25]  B. Gulyás,et al.  Evolution of microglial activation in ischaemic core and peri-infarct regions after stroke: A PET study with the TSPO molecular imaging biomarker [ 11 C]vinpocetine , 2012, Journal of the Neurological Sciences.

[26]  Mingzhang Gao,et al.  Fully automated synthesis of PET TSPO radioligands [11C]DAA1106 and [18F]FEDAA1106. , 2012, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[27]  M. Pomper,et al.  Initial Evaluation of 11C-DPA-713, a Novel TSPO PET Ligand, in Humans , 2009, Journal of Nuclear Medicine.

[28]  Jennifer M. Coughlin,et al.  Radiation Dosimetry and Biodistribution of the TSPO Ligand 11C-DPA-713 in Humans , 2012, Journal of Nuclear Medicine.

[29]  S. Chaki,et al.  Binding characteristics of [3H]DAA1106, a novel and selective ligand for peripheral benzodiazepine receptors. , 1999, European journal of pharmacology.

[30]  Ryuji Nakao,et al.  Quantitative analyses of 18F-FEDAA1106 binding to peripheral benzodiazepine receptors in living human brain. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[31]  Ming-Kai Chen,et al.  Translocator protein 18 kDa (TSPO): molecular sensor of brain injury and repair. , 2008, Pharmacology & therapeutics.

[32]  Eric Achten,et al.  Assessment of Neuroinflammation and Microglial Activation in Alzheimer’s Disease with Radiolabelled PK11195 and Single Photon Emission Computed Tomography , 2003, European Neurology.

[33]  G. L. Watkins,et al.  PET Imaging of human gliomas with ligands for the peripheral benzodiazepine binding site , 1989, Annals of neurology.

[34]  B. Gulyás,et al.  [11C]Vinpocetine: a prospective peripheral benzodiazepine receptor ligand for primate PET studies , 2005, Journal of the Neurological Sciences.

[35]  Alan A. Wilson,et al.  Voxel-Based Imaging of Translocator Protein 18Kda (TSPO) in High-Resolution PET , 2013, Journal of Cerebral Blood Flow and Metabolism.

[36]  F. Yasuno,et al.  Increased Binding of Peripheral Benzodiazepine Receptor in Alzheimer's Disease Measured by Positron Emission Tomography with [11C]DAA1106 , 2008, Biological Psychiatry.

[37]  Akiko Hatori,et al.  In vitro and ex vivo autoradiography studies on peripheral-type benzodiazepine receptor binding using [11C]AC-5216 in normal and kainic acid-lesioned rats , 2007, Neuroscience Letters.

[38]  D. Brooks,et al.  Imaging neuroinflammation in Alzheimer's disease and other dementias: Recent advances and future directions , 2015, Alzheimer's & Dementia.

[39]  Kengo Ito,et al.  Radiosynthesis and in vivo evaluation of N-[11C]methylated imidazopyridineacetamides as PET tracers for peripheral benzodiazepine receptors. , 2008, Nuclear medicine and biology.

[40]  E. Aronica,et al.  Epilepsy and brain inflammation , 2013, Experimental Neurology.

[41]  Synthesis and evaluation of N-(5-fluoro-2-phenoxyphenyl)-N-(2-[(18)F]fluoromethoxy-d(2)-5-methoxybenzyl)acetamide: a deuterium-substituted radioligand for peripheral benzodiazepine receptor. , 2005, Bioorganic & medicinal chemistry.

[42]  Gerhard Rammes,et al.  Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders , 2010, Nature Reviews Drug Discovery.

[43]  Sylvain Houle,et al.  Radiosynthesis and initial evaluation of [18F]-FEPPA for PET imaging of peripheral benzodiazepine receptors. , 2008, Nuclear medicine and biology.

[44]  S Ogawa,et al.  Neuropharmacological profile of peripheral benzodiazepine receptor agonists, DAA1097 and DAA1106. , 1999, Life sciences.

[45]  Alexander Gerhard,et al.  In vivo imaging of neuroinflammation , 2002, European Neuropsychopharmacology.

[46]  Tetsuya Suhara,et al.  Development of a new radioligand, N-(5-fluoro-2-phenoxyphenyl)-N-(2-[18F]fluoroethyl-5-methoxybenzyl)acetamide, for pet imaging of peripheral benzodiazepine receptor in primate brain. , 2004, Journal of medicinal chemistry.

[47]  S S Gambhir,et al.  Use of positron emission tomography in animal research. , 2001, ILAR journal.

[48]  B. Gulyás,et al.  Functional neuroimaging in multiple sclerosis with radiolabelled glia markers: Preliminary comparative PET studies with [11C]vinpocetine and [11C]PK11195 in patients , 2008, Journal of the Neurological Sciences.

[49]  Robert B. Innis,et al.  PET imaging with [11C]PBR28 can localize and quantify upregulated peripheral benzodiazepine receptors associated with cerebral ischemia in rat , 2007, Neuroscience Letters.

[50]  Ming-Rong Zhang,et al.  Characterization of a novel acetamidobenzoxazolone‐based PET ligand for translocator protein (18 kDa) imaging of neuroinflammation in the brain , 2014, Journal of neurochemistry.

[51]  Annelaure Damont,et al.  Comparative Evaluation of the Translocator Protein Radioligands 11C-DPA-713, 18F-DPA-714, and 11C-PK11195 in a Rat Model of Acute Neuroinflammation , 2009, Journal of Nuclear Medicine.

[52]  Masahiro Fujita,et al.  Comparison of [11C]-(R)-PK 11195 and [11C]PBR28, two radioligands for translocator protein (18 kDa) in human and monkey: Implications for positron emission tomographic imaging of this inflammation biomarker , 2010, NeuroImage.

[53]  Tetsuya Suhara,et al.  [(11)C]DAA1106: radiosynthesis and in vivo binding to peripheral benzodiazepine receptors in mouse brain. , 2003, Nuclear medicine and biology.

[54]  W. Slikker,et al.  MicroPET/CT Imaging of [18F]-FEPPA in the Nonhuman Primate: A Potential Biomarker of Pathogenic Processes Associated with Anesthetic-Induced Neurotoxicity , 2012 .

[55]  T. Taniguchi,et al.  Properties of [3H]diazepam binding sites on rat blood platelets. , 1980, Life sciences.

[56]  D. Bereczki,et al.  Vinpocetine for acute ischaemic stroke. , 2008, The Cochrane database of systematic reviews.

[57]  Masahiro Fujita,et al.  Brain and whole-body imaging in nonhuman primates of [11C]PBR28, a promising PET radioligand for peripheral benzodiazepine receptors , 2008, NeuroImage.

[58]  J. Rinne,et al.  Detection of Microglial Activation in an Acute Model of Neuroinflammation Using PET and Radiotracers 11C-(R)-PK11195 and 18F-GE-180 , 2014, The Journal of Nuclear Medicine.

[59]  Dewei Tang,et al.  Preclinical Imaging Evaluation of Novel TSPO-PET Ligand 2-(5,7-Diethyl-2-(4-(2-[18F]fluoroethoxy)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)-N,N-diethylacetamide ([18F]VUIIS1008) in Glioma , 2014, Molecular Imaging and Biology.

[60]  N. Denora,et al.  A Novel PET Imaging Probe for the Detection and Monitoring of Translocator Protein 18 kDa Expression in Pathological Disorders , 2016, Scientific Reports.

[61]  Sami S Zoghbi,et al.  Synthesis and evaluation in monkey of two sensitive 11C-labeled aryloxyanilide ligands for imaging brain peripheral benzodiazepine receptors in vivo. , 2008, Journal of medicinal chemistry.

[62]  J. Mann,et al.  PET tracers for the peripheral benzodiazepine receptor and uses thereof. , 2010, Drug discovery today.

[63]  T. Suhara,et al.  [18F]FMDAA1106 and [18F]FEDAA1106: two positron-emitter labeled ligands for peripheral benzodiazepine receptor (PBR). , 2003, Bioorganic & medicinal chemistry letters.

[64]  Denis Guilloteau,et al.  DPA-714, a New Translocator Protein–Specific Ligand: Synthesis, Radiofluorination, and Pharmacologic Characterization , 2008, Journal of Nuclear Medicine.

[65]  Jing Zhang,et al.  Mapping neuroinflammation in frontotemporal dementia with molecular PET imaging , 2015, Journal of Neuroinflammation.

[66]  Michael Kassiou,et al.  The Translocator Protein , 2011, The Journal of Nuclear Medicine.

[67]  A. Reynolds,et al.  The development of PET radioligands for imaging the translocator protein (18 kDa): What have we learned? , 2010 .

[68]  B. Kiss,et al.  PET studies on the brain uptake and regional distribution of [11C]vinpocetine in human subjects , 2002, Acta neurologica Scandinavica.

[69]  Masahiro Fujita,et al.  Kinetic evaluation in nonhuman primates of two new PET ligands for peripheral benzodiazepine receptors in brain , 2007, Synapse.

[70]  S. Jan,et al.  In vivo imaging of brain lesions with [11C]CLINME, a new PET radioligand of peripheral benzodiazepine receptors , 2007, Glia.

[71]  P Ferrara,et al.  Site-directed mutagenesis of the peripheral benzodiazepine receptor: identification of amino acids implicated in the binding site of Ro5-4864. , 1994, Molecular pharmacology.

[72]  Adriaan A Lammertsma,et al.  Imaging of neuroinflammation in Alzheimer's disease, multiple sclerosis and stroke: Recent developments in positron emission tomography. , 2016, Biochimica et biophysica acta.

[73]  S. Kurumiya,et al.  Antianxiety and antidepressant‐like effects of AC‐5216, a novel mitochondrial benzodiazepine receptor ligand , 2004, British journal of pharmacology.

[74]  Michael Kassiou,et al.  Radiolabelled molecules for imaging the translocator protein (18 kDa) using positron emission tomography. , 2009, Current medicinal chemistry.

[75]  Ming-Rong Zhang,et al.  Evaluation of N‐benzyl‐N‐[11C]methyl‐2‐ (7‐methyl‐8‐oxo‐2‐phenyl‐7,8‐dihydro‐9H‐purin‐9‐yl)acetamide ([11C]DAC) as a novel translocator protein (18 kDa) radioligand in kainic acid‐lesioned rat , 2009, Synapse.

[76]  O. Inoue,et al.  Blood flow dependence of the intratumoral distribution of peripheral benzodiazepine receptor binding in intact mouse fibrosarcoma. , 2006, Nuclear medicine and biology.

[77]  Hervé Boutin,et al.  Nuclear imaging of neuroinflammation: a comprehensive review of [11C]PK11195 challengers , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[78]  A. Reynolds,et al.  Initial evaluation in healthy humans of [18F]DPA-714, a potential PET biomarker for neuroinflammation. , 2012, Nuclear medicine and biology.

[79]  B. Tavitian,et al.  In vivo imaging of neuroinflammation in the rodent brain with [11C]SSR180575, a novel indoleacetamide radioligand of the translocator protein (18 kDa) , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[80]  E. Warburton,et al.  Strategy for improved [11C]DAA1106 radiosynthesis and in vivo peripheral benzodiazepine receptor imaging using microPET, evaluation of [11C]DAA1106 , 2007 .

[81]  M. Grégoire,et al.  Synthesis and biological evaluation of substituted [18F]imidazo[1,2-a]pyridines and [18F]pyrazolo[1,5-a]pyrimidines for the study of the peripheral benzodiazepine receptor using positron emission tomography. , 2008, Journal of medicinal chemistry.

[82]  Alan A. Wilson,et al.  Translocator Protein (18 kDa) Polymorphism (rs6971) Explains in-vivo Brain Binding Affinity of the PET Radioligand [18F]-FEPPA , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[83]  André Syrota,et al.  Synthesis of N‐(11C) methyl, N‐(methyl‐1 propyl), (chloro‐2 phenyl)‐1 isoquinoleine carboxamide‐3 (PK 11195): A new ligand for peripheral benzodiazepine receptors , 1984 .

[84]  Yuji Nagai,et al.  Novel peripheral benzodiazepine receptor ligand [11C]DAA1106 for PET: An imaging tool for glial cells in the brain , 2004, Synapse.

[85]  Annelaure Damont,et al.  Synthesis of 6-[¹⁸F]fluoro-PBR28, a novel radiotracer for imaging the TSPO 18 kDa with PET. , 2011, Bioorganic & medicinal chemistry letters.

[86]  S. Hume,et al.  Synthesis of the enantiomers of [N-methyl-11C]PK 11195 and comparison of their behaviours as radioligands for PK binding sites in rats. , 1994, Nuclear medicine and biology.

[87]  Alessandra Bertoldo,et al.  The methodology of TSPO imaging with positron emission tomography , 2015, Biochemical Society transactions.

[88]  Roger N Gunn,et al.  An 18-kDa Translocator Protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28 , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[89]  Hidehiko Takahashi,et al.  Quantitative Analysis of Peripheral Benzodiazepine Receptor in the Human Brain Using PET with 11C-AC-5216 , 2009, Journal of Nuclear Medicine.

[90]  Alan A. Wilson,et al.  Positron-emission tomography imaging of the TSPO with [(18)F]FEPPA in a preclinical breast cancer model. , 2013, Cancer biotherapy & radiopharmaceuticals.

[91]  Shane M. Wilkinson,et al.  [18F]DPA-714: Direct Comparison with [11C]PK11195 in a Model of Cerebral Ischemia in Rats , 2013, PloS one.

[92]  M. Grégoire,et al.  In vivo imaging of neuroinflammation: a comparative study between [18F]PBR111, [11C]CLINME and [11C]PK11195 in an acute rodent model , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[93]  S. Galiègue,et al.  Peripheral benzodiazepine receptors and mitochondrial function , 2002, Neurochemistry International.

[94]  Ming-Rong Zhang,et al.  Synthesis and evaluation of new (18)F-labelled acetamidobenzoxazolone-based radioligands for imaging of the translocator protein (18 kDa, TSPO) in the brain. , 2014, Organic & biomolecular chemistry.

[95]  J. Hirvonen,et al.  Increased In Vivo Expression of an Inflammatory Marker in Temporal Lobe Epilepsy , 2012, The Journal of Nuclear Medicine.

[96]  Alan A. Wilson,et al.  Quantitative imaging of neuroinflammation in human white matter: A positron emission tomography study with translocator protein 18 kDa radioligand, [18F]‐FEPPA , 2014, Synapse.